North America Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR747
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Nasal sprays are the devices that help in the delivery of the drug through the nose in the nasal cavity to treat allergy and other problems related to brain inflammation, diabetes, dental problems, central nervous system. Allergy is a condition in which immune system of the body reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients. There are different types of nasal spray available in the market such as decongestion nasal spray, saline nasal spray and steroid nasal spray. Decongestants are used to treat nasal congestion which provides short-term relief for a blocked or stuffy nose. Decongestion nasal spray comprises of drugs which shrinks the swollen membranes and open ups the airways of the nasal part which makes the breathing process easier.

North America nasal spray market is expected to reach with healthy CAGR of 6.4% in the forecast period of 2018 to 2025. The new market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation:

By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care), Country (U.S., Canada, Mexico)

Major growing sectors under the market segmentation are as follows:

In product type, decongestion nasal spray segment is expected to dominate the global nasal spray market due to the rising problems associated with the decongestion of conditions such as colds & flu, hay fever, allergic reactions and sinusitis are helping the segment to grow in the forecast period of 2018 to 2025.

In therapeutic class, antihistamine segment is expected to dominate the market due to rising antihistamine usage amongst population for different diseases such as congestion, runny nose, sneezing, itching, nasal swelling and different products availability by the companies is expected to dominate the market, whereas nasal steroids are available for both prescription and over the counter usage, and fast effective results are the major growth factors of the market.

In container design, pump bottles segment is expected to dominate the market due to the user friendly and wide offering of the over the counter products by the companies and it is expected to fuel the growth of pump bottles market in the forecast period. However, new advancement associated with the pressurized canisters.

In doses form, multi does segment is expected to dominate the market due to the wide availability in different dose volumes and user friendly attributes it is expected to drive the market of unit/single dose in the forecast period.

In prescription segment, prescription based segment is expected to dominate the market due to the rising chances of seasonal associated nasal problems and also for the various diseases such as pulmonary, dental anesthesia and others which leads the growth of prescription based segment is expected to fuel in the forecast period of 2018 to 2025.

In application segment, nasal congestion segment is expected to dominate the market due to the rising cases of nasal congestion diseases such as runny nose, sinus pain, mucus buildup and also availability of the over the counter products, nasal congestion segment is expected to dominate market. However, allergic and non-allergic rhinitis is the fastest growing segment among all because of the rising problems amongst the population such as antihistamines, nasal corticosteroids, hay fever and other, also seasonal imbalance is one of the reasons in raising the allergic and non-allergic rhinitis segment to grow in the forecast period with the highest CAGR.

The key market players for North Americanasal spray market are listed below:

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20

1.2 MARKET DEFINITION 20

1.3 OVERVIEW OF NASAL SPRAY MARKET 21

1.4 CURRENCY AND PRICING 22

1.5 LIMITATION 22

1.6 MARKETS COVERED 22

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25

2.2 GEOGRAPHIC SCOPE 26

2.3 YEARS CONSIDERED FOR THE STUDY 27

2.4 CURRENCY AND PRICING 27

2.5 RESEARCH METHODOLOGY 28

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31

2.7 SECONDARY SOURCES 32

2.8 ASSUMPTIONS 32

3 MARKET OVERVIEW 33

3.1 DRIVERS 35

3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 35

3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 36

3.1.3 INCREASE IN INFECTION & ALLERGIC CASES 37

3.2 RESTRAINTS 37

3.2.1 PRODUCT RECALLS 37

3.3 OPPORTUNITIES 38

3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY 38

3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 38

3.4 CHALLENGES 39

3.4.1 REGULATORY HURDLES 39

4 EXECUTIVE SUMMARY 40

5 PREMIUM INSIGHTS 44

?

6 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE 46

6.1 OVERVIEW 47

6.2 DECONGESTION NASAL SPRAY 49

6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY 50

6.4 STEROID NASAL SPRAY 52

6.5 OTHERS 53

7 NORTH AMERICA N ASAL SPRAY MARKET, BY CONTAINER DESIGN 54

7.1 OVERVIEW 55

7.2 PRESSURIZED CANISTERS 57

7.3 PUMP BOTTLES 58

8 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM 59

8.1 OVERVIEW 60

8.2 UNIT/SINGLE DOSE 62

8.3 BI DOSE 64

8.4 MULTI DOSE 65

9 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 67

9.1 OVERVIEW 68

9.2 ANTIHISTAMINE 70

9.3 NASAL STEROIDS 72

9.4 MAST CELL INHIBITOR 73

9.5 ANTICHOLINERGIC 74

10 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION 75

10.1 OVERVIEW 76

10.2 ALLERGIC AND NON-ALLERGIC RHINITIS 78

10.3 NASAL CONGESTION 80

10.4 CENTRAL NERVOUS SYSTEM DISORDERS 81

10.5 VACCINATION 82

10.6 OTHERS 83

11 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE 84

11.1 OVERVIEW 85

11.2 PRESCRIPTION BASED 87

11.3 OVER THE COUNTER 88

?

12 NORTH AMERICA NASAL SPRAY MARKET, BY END USER 90

12.1 OVERVIEW 91

12.2 HOSPITALS 93

12.3 CLINICS 94

12.4 HOME CARE SETTINGS 95

12.5 COMMUNITY HEALTH CARE 96

13 NORTH AMERICA NASAL SPRAY MARKET, BY GEOGRAPHY 97

13.1 NORTH AMERICA 97

13.1.1 INCREASING MANUFACTURING CAPABILITIES IN U.S. 97

13.1.2 U.S. 105

13.1.3 CANADA 109

13.1.4 MEXICO 113

14 NORTH AMERICA NASAL SPRAY MARKET, COMPANY LANDSCAPE 117

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 117

15 COMPANY PROFILE 118

15.1 PFIZER INC. 118

15.1.1 COMPANY OVERVIEW 118

15.1.2 REVENUE ANALYSIS 118

15.1.3 COMPANY SHARE ANALYSIS 119

15.1.4 PRODUCT PORTFOLIO 120

15.1.5 RECENT DEVELOPMENTS 120

15.2 CIPLA INC. 121

15.2.1 COMPANY OVERVIEW 121

15.2.2 REVENUE ANALYSIS 121

15.2.3 COMPANY SHARE ANALYSIS 122

15.2.4 PRODUCT PORTFOLIO 122

15.2.5 RECENT DEVELOPMENTS 123

15.3 BAYER AG 124

15.3.1 COMPANY OVERVIEW 124

15.3.2 REVENUE ANALYSIS 124

15.3.3 COMPANY SHARE ANALYSIS 125

15.3.4 PRODUCT PORTFOLIO 125

15.3.5 RECENT DEVELOPMENTS 125

?

15.4 INNOVUS PHARMACEUTICALS, INC. 126

15.4.1 COMPANY OVERVIEW 126

15.4.2 REVENUE ANALYSIS 126

15.4.3 COMPANY SHARE ANALYSIS 127

15.4.4 PRODUCT PORTFOLIO 127

15.4.5 RECENT DEVELOPMENTS 127

15.5 GLAXOSMITHKLINE PLC. 128

15.5.1 COMPANY OVERVIEW 128

15.5.2 REVENUE ANALYSIS 128

15.5.3 PRODUCT PORTFOLIO 129

15.5.4 RECENT DEVELOPMENTS 129

15.6 ADAPT PHARMA, INC. 130

15.6.1 COMPANY OVERVIEW 130

15.6.2 GEOGRAPHIC PRESENCE 130

15.6.3 PRODUCT PORTFOLIO 131

15.6.4 RECENT DEVELOPMENTS 131

15.7 AISHWARYA GROUP 132

15.7.1 COMPANY OVERVIEW 132

15.7.2 PRODUCT PORTFOLIO 132

15.7.3 RECENT DEVELOPMENTS 132

15.8 ALLERGAN 133

15.8.1 COMPANY OVERVIEW 133

15.8.2 REVENUE ANALYSIS 133

15.8.3 PRODUCT PORTFOLIO 133

15.8.4 RECENT DEVELOPMENTS 134

15.9 ARIUS FORMULATIONS PVT LTD 135

15.9.1 COMPANY OVERVIEW 135

15.9.2 PRODUCT PORTFOLIO 135

15.9.3 RECENT DEVELOPMENTS 135

15.10 AURENA 136

15.10.1 COMPANY OVERVIEW 136

15.10.2 GEOGRAPHIC PRESENCE 136

15.10.3 PRODUCT PORTFOLIO 137

15.10.4 RECENT DEVELOPMENTS 137

15.11 CATALENT, INC 138

15.11.1 COMPANY OVERVIEW 138

15.11.2 REVENUE ANALYSIS 138

15.11.3 PRODUCT PORTFOLIO 139

15.11.4 RECENT DEVELOPMENTS 139

?

15.12 EGALET CORPORATION 140

15.12.1 COMPANY OVERVIEW 140

15.12.2 REVENUE ANALYSIS 140

15.12.3 PRODUCT PORTFOLIO 141

15.12.4 RECENT DEVELOPMENTS 141

15.13 J PHARMACEUTICALS 142

15.13.1 COMPANY OVERVIEW 142

15.13.2 PRODUCT PORTFOLIO 142

15.13.3 RECENT DEVELOPMENTS 142

15.14 LEEFORD HEALTHCARE LTD 143

15.14.1 COMPANY OVERVIEW 143

15.14.2 GEOGRAPHIC PRESENCE 143

15.14.3 PRODUCT PORTFOLIO 144

15.14.4 RECENT DEVELOPMENTS 144

15.15 MYLAN N.V. 145

15.15.1 REVENUE ANALYSIS 145

15.15.2 PRODUCT PORTFOLIO 146

15.15.3 RECENT DEVELOPMENTS 146

15.16 SANDOZ INTERNATIONAL GMBH 147

15.16.1 COMPANY OVERVIEW 147

15.16.2 GEOGRAPHIC PRESENCE 147

15.16.3 PRODUCT PORTFOLIO 148

15.16.4 RECENT DEVELOPMENTS 148

15.17 ST. RENATUS 149

15.17.1 COMPANY OVERVIEW 149

15.17.2 PRODUCT PORTFOLIO 149

15.17.3 RECENT DEVELOPMENTS 149

15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD. 150

15.18.1 COMPANY OVERVIEW 150

15.18.2 REVENUE ANALYSIS 150

15.18.3 PRODUCT PORTFOLIO 151

15.18.4 RECENT DEVELOPMENTS 151

15.19 ULTRATECH INDIA LIMITED 152

15.19.1 COMPANY OVERVIEW 152

15.19.2 PRODUCT PORTFOLIO 152

15.19.3 RECENT DEVELOPMENTS 152

16 RELATED REPORTS 153

LIST OF FIGURES

FIGURE 1 NORTH AMERICA NASAL SPRAY MARKET: SEGMENTATION 18

FIGURE 2 NORTH AMERICA NASAL SPRAY MARKET: DATA TRIANGULATION 21

FIGURE 3 NORTH AMERICA NASAL SPRAY MARKET: RESEARCH SNAPSHOT 22

FIGURE 4 NORTH AMERICA NASAL SPRAY MARKET: BOTTOM UP APPROACH 23

FIGURE 5 NORTH AMERICA NASAL SPRAY MARKET: TOP DOWN APPROACH 23

FIGURE 6 NORTH AMERICANASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS 24

FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA NASAL SPRAY MARKET 27

FIGURE 8 NORTH AMERICA NASAL SPRAY MARKET: SEGMENTATION 35

FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NASAL SPRAY MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 36

FIGURE 10 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025 37

FIGURE 11 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025 38

FIGURE 12 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017 40

FIGURE 13 NORTH AMERICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017 48

FIGURE 14 NORTH AMERICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2017 53

FIGURE 15 NORTH AMERICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017 61

FIGURE 16 NORTH AMERICA NASAL SPRAY MARKET: BY APPLICATION, 2017 69

FIGURE 17 NORTH AMERICA NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017 78

FIGURE 18 NORTH AMERICA NASAL SPRAY MARKET: BY END USER, 2017 84

FIGURE 19 NORTH AMERICA NASAL SPRAY MARKET SNAPSHOT (2017) 91

FIGURE 20 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017) 92

FIGURE 21 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 92

FIGURE 22 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 93

FIGURE 23 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 93

FIGURE 24 NORTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 110

LIST OF TABLES

TABLE 1 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION) 41

TABLE 2 NORTH AMERICA DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 42

TABLE 3 NORTH AMERICA SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 44

TABLE 4 NORTH AMERICA STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 45

TABLE 5 NORTH AMERICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 46

TABLE 6 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION) 49

TABLE 7 NORTH AMERICA PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 50

TABLE 8 NORTH AMERICA PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 51

TABLE 9 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION) 54

TABLE 10 NORTH AMERICA UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 56

TABLE 11 NORTH AMERICA BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 57

TABLE 12 NORTH AMERICA MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 59

TABLE 13 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION) 62

TABLE 14 NORTH AMERICA ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 64

TABLE 15 NORTH AMERICA NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 65

TABLE 16 NORTH AMERICA MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 66

TABLE 17 NORTH AMERICA ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 67

TABLE 18 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION) 70

TABLE 19 NORTH AMERICA ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 72

TABLE 20 NORTH AMERICA NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 73

TABLE 21 NORTH AMERICA CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 74

TABLE 22 NORTH AMERICA VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 75

TABLE 23 NORTH AMERICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 76

TABLE 24 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION) 79

TABLE 25 NORTH AMERICA PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 80

TABLE 26 NORTH AMERICA OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 82

TABLE 27 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION) 85

TABLE 28 NORTH AMERICA HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 86

TABLE 29 NORTH AMERICA CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 87

TABLE 30 NORTH AMERICA HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 88

TABLE 31 NORTH AMERICA COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 89

TABLE 32 NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025(USD MILLION) 94

TABLE 33 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 94

TABLE 34 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 95

TABLE 35 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 95

TABLE 36 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 96

TABLE 37 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 96

TABLE 38 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 97

TABLE 39 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 97

TABLE 40 U.S. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 98

TABLE 41 U.S. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 98

TABLE 42 U.S. NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 99

TABLE 43 U.S. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 99

TABLE 44 U.S. NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 100

TABLE 45 U.S. NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 100

TABLE 46 U.S. NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 101

TABLE 47 CANADA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 102

TABLE 48 CANADA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 102

TABLE 49 CANADA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 103

TABLE 50 CANADA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 103

TABLE 51 CANADA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 104

TABLE 52 CANADA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 104

TABLE 53 CANADA NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 105

TABLE 54 MEXICO NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 106

TABLE 55 MEXICO NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 106

TABLE 56 MEXICO NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 107

TABLE 57 MEXICO NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 107

TABLE 58 MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 108

TABLE 59 MEXICO NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 108

TABLE 60 MEXICO NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 109

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group

select a license
Single User License
USD 2500 INR 179800
Corporate User License
USD 3200 INR 230144

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com